Skip to main content
. 2023 Jul 18;14:4296. doi: 10.1038/s41467-023-39864-w

Table 4.

Standardized province-specific prevalence of any DR and VTDR among Chinese adults with diabetes

Province N Any DR VTDR
Prevalence (95% CI)a Rank Prevalence (95% CI)a Rank
Guizhou 1727 9.9 (8.3–11.5) 1 1.8 (1.2–2.4) 3
Fujian 1744 10.9 (9.3–12.5) 2 2.2 (1.5–2.9) 6
Tianjin 1729 11.2 (9.5–12.9) 3 2.7 (1.9–3.5) 12
Qinghai 802 11.5 (9.0–13.9) 4 3.7 (2.2–5.3) 23
Guangxi 1584 11.5 (9.6–13.4) 5 1.64 (0.81–2.46) 2
Jiangsu 1768 11.6 (9.9–13.4) 6 2.6 (1.8–3.4) 11
Hubei 1607 12.0 (10.0–14.1) 7 1.9 (1.1–2.7) 5
Shanxi 1858 12.4 (10.7–14.0) 8 2.8 (2.0–3.6) 13
Hunan 1676 12.5 (10.6–14.4) 9 2.5 (1.4–3.5) 9
Shanghai 1723 12.6 (10.9–14.4) 10 2.5 (1.7–3.3) 10
Jiangxi 1453 14.4 (11.9–16.8) 11 1.27 (0.61–1.94) 1
Ningxia 1719 15.1 (13.1–17.1) 12 1.9 (1.2–2.5) 4
Tibet 578 15.2 (11.8–18.7) 13 3.7 (2.3–5.2) 24
Liaoning 1701 15.5 (13.5–17.5) 14 3.7 (2.7–4.8) 22
Hebei 1790 15.6 (13.6–17.6) 15 3.4 (2.4–4.5) 18
Anhui 1636 15.7 (13.5–17.8) 16 2.4 (1.6–3.2) 7
Zhejiang 1639 16.0 (13.9–18.1) 17 3.5 (2.5–4.5) 19
Guangdong 1570 16.1 (13.8–18.3) 18 3.0 (2.0–4.0) 14
Inner Mongolia 1633 16.5 (14.4–18.6) 19 2.4 (1.7–3.2) 8
Yunnan 1719 16.8 (14.7–18.9) 20 3.8 (2.7–4.9) 25
Sichuan 2145 17.4 (15.5–19.4) 21 3.9 (3.1–4.8) 26
Jilin 1568 17.9 (15.6–20.2) 22 4.5 (3.3–5.6) 28
Shaanxi 1698 18.1 (15.9–20.2) 23 4.0 (3.0–5.0) 27
Beijing 1708 18.6 (16.3–20.9) 24 4.7 (3.6–5.9) 29
Hainan 1462 18.7 (16.2–21.2) 25 3.1 (2.0–4.2) 15
Gansu 1710 18.7 (16.5–20.9) 26 3.7 (2.7–4.6) 21
Xinjiang 856 19.4 (16.4–22.5) 27 3.4 (2.2–4.6) 17
Chongqing 1671 19.8 (17.4–22.1) 28 3.1 (2.1–4.1) 16
Henan 2162 24.6 (22.3–26.8) 29 3.6 (2.8–4.5) 20
Heilongjiang 1761 27.0 (24.5–29.5) 30 6.3 (5.1–7.5) 31
Shandong 2167 29.1 (26.5–31.6) 31 6.2 (5.0–7.3) 30

Any DR any diabetic retinopathy. VTDR vision-threatening diabetic retinopathy. CI confidence interval.

aData were presented as weighted percentage (95% confidence interval), which were direct standardized by the sex- and age- structure of adults with diabetes aged 18–74 years in China in 2018 from the China Chronic Disease and Risk Factors Surveillance system.

Source data are provided as a Source Data file.